Medical organisations and public health experts question US President Trump’s childhood vaccine policy
The 11 vaccines to remain recommended for all children include those against measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus and varicella. Vaccines against respiratory syncytial virus, hepatitis A and B, meningococcal disease and dengue will instead be recommended for certain high-risk groups or populations.
Why US President signed executive order that reduces number of childhood vaccines from 18 to 11
Karl Jablonowski, CHD’s senior research scientist, said the “real shakeup” comes from aligning US childhood vaccination policy with the findings of the HHS report and “placing it’s upkeep with Kennedy, through the HHS Task Force on Safer Childhood Vaccines.”
Chief architect of lab manufacture of Covid risks perjury charges as Senate Homeland Security Committee issues subpoena to testify
In an interview with Semafor, Paul said he will also ask Fauci about the destruction of federal records and about the pre-emptive pardon former President Joe Biden granted him last year. The pardon shields Fauci from federal prosecution for his official acts dating back to 2014.
‘The people have had enough’: Moment of Truth sold-out conference signals growing power of health freedom movement
Children’s Health Defence hosted its sold-out “Moment of Truth” conference November 7-9 in Austin, Texas, drawing about 1,000 attendees in person and another 1,000 online. Meanwhile, Vice President JD Vance praised US Health Secretary Robert F. Kennedy Jr. at the MAHA Summit on November 14, highlighting the movement’s growing influence over health policy.
US health secretary’s ‘alternative medicine’ push inspired quest to ‘live forever’ via snake venom, urine therapy
Biohacking is a big tent, combining Silicon Valley technology, Burning Man spirituality and health libertarianism. If anything unites this crowd, it is a distrust of the medical status quo – particularly the pharmaceutical industry – and an appetite for tech-heavy alternatives.









